维普期刊资源整合服务平台（V6.5）

45篇 您的检索式：作者名="MAASSEN C"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	Microbial diversity and functional characterization of sediments from reservoirs of different trophic state显示文摘	Wobus A Bleul C Maassen S	2003	FEMS Microbiology Ecology2003，46，：	1
2	Microbial diversity and function characterization of sediments from reservoir of different trophic state显示文摘	Wobus A Bleul C Maassen S	2003	FEMS Microbiol Ecol2003，46，：	1
3	Anticardiolipin antibodies directed not to cardiolipin but to a plasma cofactor显示文摘	Galli M Comfurius P Maassen C	1990	Lancet1990，335，8705：	1
4	Improved discrimination of prostate cancer and benign prostatic hyperplasia by means of the quotient of free and total PSA 显示文摘	Weckermann D Maassen C Wawroschek F	1999	Int Urol Nephol1999，31，3：	1
5	Anticardiolipin antibodies(ACA) directed not to cardiolipin but to a plasma cofactor显示文摘	Galli M Comfuius P Maassen C	1990	Lancet1990，335，8705：	1
6	Solid lipid nanoparticles (SLN) as potential carriers for human use:Interaction with human granulocytes显示文摘	Muller RH Maassen S Schwarz C	1997	J Control Release1997，47，3：	1
7	Solid lipid nanoparticles(SLN) as potential carrier for human use:interaction with human granulocytes 显示文摘	Muller RH Maassen S Schwarz C	1997	J Control Release1997，47，：	1
8	Improved discrimination of prostate cancer and benign prostatic hyperplasia by means of the quotient of free and total PSA显示文摘	Weckermann D Maassen C Wawroschek F	1999	Int Urol Nephrol1999，31，3：	1
9	Anticardiolipin antibodies (ACA) are directed not to cardiolipin but to a plasma protein cofactor 显示文摘	Galli M Comfurius P Maassen C	1990	Lancet1990，335，：	1
10	Instruments for oral disease-intervention strategies:recombinant lactobacillus casei expressing tetanus toxin fragment C for vaccination or myelin proteins for oral tolerance induction in multiple sclerosis显示文摘	MAASSEN C B M L AMAN J D HEIJNE M J	1999	Vaccine1999，17，17：	1
11	Correlation of Room Tem- perature Shelf Aging with Accelerated Aging显示文摘	Youmans R A Maassen G C	1955	Industrial & Engineering Chemistry Research1955，47，7：	1
12	Solid lipid nanoparticles(SLN) as potential carrier for human use: interaction with human granulocytes显示文摘	Maassen S Schwarz C	1997	J Control Release1997，47，：	1
13	Solid lipid nanoparticles (SLN) as potential carrier for human use: interaction with human granulocytes显示文摘	Muller RH Maassen S Schwarz C	1997	J Control Release1997，47，：	1
14	Improved discrimination of prostate cancer and benign prostatic hy- perplasia by means of the quotient of free and total PSA显示文摘	Weckermann D Maassen C Wawroschek F	1999	Int Urol Nephrol1999，31，3：	1
15	Strain-dependent induction of cytokine profiles in the gut by orally administered Lactobacillus strains显示文摘	MAASSEN C B VAN HOLTEN N C BALK F	2000	Vaccine2000，18，23：	1
16	Growth phase of orally administered Laetobacillus strains differentially affects IgG1/IgG2a ratio for soluble antigens: implications for vaccine development 显示文摘	Maassen CB Boersma WJ Van-Holten-Neelen C	2003	Vaccine2003，21，2122：	1
17	Solid lipid nanoparticles(SLN) as potential carrier for human use:Interaction with human granulocytes显示文摘	Muller RH Maassen S Schwarz C	1997	J Control Release1997，47，3：	1
18	Instruments for oral disease-intervention strategies:Recombinant Lactobacillus casei expressing tetanus toxin fragment C for vaccination or myelin proteins for oral tolerance induction in multiple sclerosis显示文摘	MAASSEN C LAMAN J DEN BAK-GLASHOUWER M H	1999	Vaccine1999，17，：	1
19	Improved anti- IgG and HSA affinity ligands: Clinical application of VHH antibody technology显示文摘	Klooster R Maassen B T H Stam J C	2007	Immunol Meth2007，324，12：	1
20	Strain-dependent induction of cytokine profiles in the gut by orally administered Lactobacillus strains显示文摘	MAASSEN C B BALK F LEER M J	2000	Vaccine2000，18，23：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示